| Patient | Thomas Jefferson |
|---|---|
| Date of birth | 1743-04-13 |
| Identifiers | MRN HR-EN005-SYN-TD; SSN (made up) 000-05-2276 |
| Document date | 1790-08-13 |
| Author | Nathaniel Beaumont-Ruiz, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three-month review of migraine prevention. [S]
Mr. Jefferson returns twelve weeks after starting propranolol and eight weeks after raising it to 120 mg. His diary shows 3 migraine days in the past four weeks and one in the four weeks before that, with no attack lasting more than a day; each was treated with sumatriptan and naproxen, and he was pain-free within two hours in two of the three. Acute medicine was used on 3 days. He has had no tiredness, dizziness or wheeze, and his fingers are cold only on cool mornings. His mood is good. He saw the hand therapist five weeks ago, wears a wrist splint for long writing and now writes for about two hours with breaks. His HIV, hepatitis C and hepatitis B tests from the preventive visit were nonreactive and his FIT was negative, and he was told by phone. [S]
| Element | Detail |
|---|---|
| Migraine days | 3 in the past four weeks, from 13 before prevention |
| Acute medicine | 3 days; pain-free at two hours in 2 of 3 attacks |
| Propranolol | 120 mg each evening for eight weeks; cold fingers on cool mornings |
| Disability | MIDAS 13 (grade III), from 39; HIT-6 54, from 66 |
| Mood | PHQ-9 3; GAD-7 4 |
| Screening results | HIV, hepatitis C and hepatitis B nonreactive; FIT negative |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good |
| Respiratory | Negative | No wheeze or breathlessness |
| Neurological | Positive | Three short migraine attacks in four weeks; no new features |
| Musculoskeletal | Positive | Right wrist stiff after long writing, better with the splint |
| Psychiatric | Negative | Mood good; PHQ-9 3 |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a week | One tablet at headache onset, may repeat once after 12 hours; no more than two days a week | Oral route | 1790-05-07 | active | S |
| Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a week | One tablet with the acute medicine when nausea is present, no more than once a day | Oral route | 1790-05-07 | active | S |
| Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a month | One tablet at attack onset with naproxen, may repeat once after 2 hours; up to 200 mg a day | Oral route | 1790-05-21 | active | S |
| Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine prevention | One capsule each evening | Oral route | 1790-05-21 to 1790-06-18 | completed | S |
| Propranolol extended-release 120 mg oral capsule, one capsule each evening, for migraine prevention | One capsule each evening | Oral route | 1790-06-18 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1790-08-13 | Body height | 189 | cm | S |
| 1790-08-13 | Body weight | 76.6 | kg | S |
| 1790-08-13 | Body mass index (BMI) [Ratio] | 21.4 | kg/m2 | S |
| 1790-08-13 | Systolic blood pressure | 112 | mm[Hg] | S |
| 1790-08-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1790-08-13 | Heart rate | 58 | /min | S |
| 1790-08-13 | Respiratory rate | 14 | /min | S |
| 1790-08-13 | Body temperature | 36.6 | Cel | S |
| 1790-08-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1790-08-13 | Because of your headaches on how many days in the last 3 months did you miss work or school [PhenX] | 3 | d | S | ||
| 1790-08-13 | Because of your headaches on how many days in the last 3 months was your productivity at work or school reduced by half or more [PhenX] | 5 | d | S | ||
| 1790-08-13 | Because of your headaches on how many days in the last 3 months did you not do household work [PhenX] | 1 | d | S | ||
| 1790-08-13 | Because of your headaches on how many days in the last 3 months was your productivity in house-hold work reduced by half or more [PhenX] | 2 | d | S | ||
| 1790-08-13 | Because of your headaches on how many days in the last 3 months did you miss family, social, or leisure activities [PhenX] | 2 | d | S | ||
| 1790-08-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1790-08-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | {score} | S |
Vital signs recorded on 1790-08-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 112/72, pulse 58 |
| Neurological | Normal |
| Musculoskeletal | Right wrist range of motion unchanged; grip slightly stronger |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent disabling headaches since early adulthood, in bouts lasting days to weeks, now in the seventh day of a bout; under evaluation, with a two-week headache diary and a headache medicine consultation; no red flags | resolved | confirmed | R51.9 | S — Synthetic presenting problem anchored to his documented periodical headaches; superseded when the consultation confirmed migraine without aura. |
| Migraine without aura, episodic, with bouts of near-daily attacks lasting two to three weeks; ICHD-3 criteria met in a two-week diary; synthetic modern diagnosis linked to his documented periodical headaches, which historians have usually but not unanimously called migraine | active | confirmed | G43.009 | S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0013), so this is not a claim about his real diagnosis. |
| Stiffness and weakness of the right wrist and hand after a dislocation that healed out of place in early middle age; writing is slow and painful after about an hour | active | confirmed | M25.631 | S — Synthetic modern coding of the documented badly healed right wrist dislocation. |
| Common cold with nasal congestion and facial pressure, without bacterial sinusitis, early in propranolol prevention; resolved | resolved | confirmed | J00 | S — Synthetic acute illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Red-flag screen (SNNOOP10): systemic signs, neurological signs, sudden or new pattern, onset after 50, positional or Valsalva features, papilledema, progressive course | Every visit | Completed today | No red flags |
| Survey | Headache diary: headache and migraine days, attack features, triggers | Every visit | Completed today | 3 migraine days in the past four weeks; 1 in the four weeks before |
| Medication safety | Acute-medicine days (medication overuse headache limits: triptan fewer than 10, NSAID fewer than 15 days a month) | Every visit | Completed today | Acute medicine on 3 days in four weeks |
| Medication safety | Acute treatment response (pain-free at two hours, return to work) | Every visit | Completed today | Pain-free at two hours in 2 of 3 attacks |
| Medication safety | Propranolol tolerability: pulse, blood pressure, tiredness, exercise tolerance, wheeze, cold hands, sleep | Four weeks after starting or changing the dose, then each visit | Completed today | Pulse 58, blood pressure 112/72; cold fingers on cool mornings only; no wheeze or tiredness |
| Examination | Preventive efficacy (at least 50% fewer migraine days) | At two to three months on an adequate dose | Completed today | Migraine days 13 to 3 in four weeks (77% fewer) after twelve weeks, eight of them on 120 mg |
| Survey | Disability (MIDAS, recorded as its five items, and HIT-6) | At baseline and after about three months of prevention | Completed today | MIDAS items 3, 5, 1, 2 and 2 days, total 13 (grade III), from 39; HIT-6 54, from 66 |
| Survey | Mood (PHQ-9) and anxiety (GAD-7), including on a beta-blocker | At baseline, four to six weeks after starting a preventive that can affect mood, then at each review | Completed today | PHQ-9 3, item 9 scored 0; GAD-7 4 |
| Imaging | Neuroimaging | Only for red flags or a change in pattern | Not indicated | No red flags or change in pattern |
| Self-management | Sleep, meals, caffeine and work-stress plan | Every visit | Completed today | Sleep, meals and caffeine steady; breaks from reading every hour |
| Referral | Occupational therapy visit for the right wrist and writing | Within four weeks of intake | Completed today | Seen by the hand therapist five weeks ago; splint and home exercises |
Goal progress:
Immunizations given today: Hepatitis B vaccine (HepB-CpG), second of two doses [S]
Guideline basis: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024); The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019); Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: Second hepatitis B vaccine dose given today. Review in three months, or sooner if a bout breaks through. Influenza and COVID-19 vaccines in the autumn. [S]